13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
80 檔
20.4%
在 Q4 2025 申报期间，Blue Owl Capital Holdings LP（CIK: 0001858703）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$6.6亿，共持有 80 个公开申报仓位。
Blue Owl Capital Holdings LP 在 Q4 2025 进行了结构性的板块轮动与仓位换股。在开立 11 个全新仓位及加仓 13 档持股的同时，亦同步清仓 7 档并减仓 13 档标的。
在资产配置集中度方面，Blue Owl Capital Holdings LP 的前 5 大核心持股（包含 ENGENE HOLDINGS INC, NCDL, OBDC 等）合计占整体申报市值的 20.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Engene Holdings Inc | 股票-其他 | 9.37% | -8.08% | EXIT | |
| 2 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 8.82% | -3.32% | -30.66% | |
| 3 | OBDC | Blue Owl Capital CORP | 股票-金融 | 8.06% | -2.73% | — | |
| 4 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 8.02% | -4.40% | +16.58% | |
| 5 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 7.51% | -3.07% | -6.37% | |
| 6 | CMPX | Compass Therapeutics Inc | 股票-其他 | 5.74% | -2.99% | +33.76% | |
| 7 | HLLY | Holley Inc | 股票-其他 | 5.29% | -1.81% | -14.72% | |
| 8 | CNTX | Context Therapeutics Inc | 股票-其他 | 3.37% | -3.34% | +0.34% | |
| 9 | CNDT | Conduent Inc | 股票-其他 | 2.86% | -0.62% | +8.20% | |
| 10 | RPTX | Repare Therapeutics Inc | 股票-其他 | 2.76% | — | — | |
| 11 | CVEO | Civeo CORP | 股票-其他 | 2.62% | -1.28% | EXIT | |
| 12 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 2.27% | +1.00% | -6.36% | |
| 13 | EYPT | Eyepoint Inc | 股票-其他 | 2.21% | -1.52% | +6.80% | |
| 14 | PCOR | Procore Technologies Inc | 股票-科技 | 2.12% | — | — | |
| 15 | DELL | Dell Technologies -c | 股票-科技 | 2.09% | +1.53% | +2.89% | |
| 16 | 4XC1 | Kalvista Pharmaceuticals Inc | 股票-其他 | 1.79% | -1.16% | EXIT | |
| 17 | MPLT | Maplight Therapeutics Inc | 股票-其他 | 1.77% | -1.55% | — | |
| 18 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 1.76% | — | -73.36% | |
| 19 | IMA | Imagenebio Inc | 股票-其他 | 1.75% | -0.48% | +52.29% | |
| 20 | IMMX | Immix Biopharma Inc | 股票-其他 | 1.59% | -0.66% | — | |
| 21 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.51% | -0.78% | -49.66% | |
| 22 | IMRX | Immuneering CORP - Class A | 股票-其他 | 1.35% | — | +20.91% | |
| 23 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 1.30% | -0.22% | -57.74% | |
| 24 | ORIC | Oric Pharmaceuticals Inc | 股票-其他 | 1.30% | +0.14% | — | |
| 25 | PAYO | Payoneer Global Inc | 股票-其他 | 1.23% | — | — | |
| 26 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.12% | -1.01% | EXIT | |
| 27 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.08% | — | -17.70% | |
| 28 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 1.05% | -0.91% | -58.00% | |
| 29 | CMPS | Compass Pathways PLC | 股票-其他 | 1.00% | +0.96% | NEW | |
| 30 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.91% | -0.58% | — | |
| 31 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 0.90% | -0.84% | +96.95% | |
| 32 | NU | Nu Holdings Ltd. | 股票-金融 | 0.90% | — | — | |
| 33 | LENZ | Lenz Therapeutics Inc | 股票-其他 | 0.74% | -0.60% | — | |
| 34 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 0.74% | — | -34.67% | |
| 35 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.51% | -0.08% | +60.34% | |
| 36 | JANX | Janux Therapeutics Inc | 股票-其他 | 0.43% | — | — | |
| 37 | CHYM | Chime Financial Inc-cl A | 股票-其他 | 0.31% | +0.28% | NEW | |
| 38 | EPD | Enterprise Products Partners | 股票-能源 | 0.31% | -0.32% | EXIT | |
| 39 | FLD | Fold Holdings Inc | 股票-其他 | 0.30% | -0.24% | — | |
| 40 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.25% | -0.07% | — | |
| 41 | ✓ | Alpha Tau Medical LTD | 股票-其他 | 0.12% | — | — | |
| 42 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.11% | -0.10% | EXIT | |
| 43 | ✓ | 股票-其他 | 0.08% | -0.03% | EXIT | ||
| 44 | OMDA | Omada Health Inc | 股票-其他 | 0.07% | — | — | |
| 45 | TTAN | Servicetitan Inc-a | 股票-科技 | 0.07% | — | -54.26% | |
| 46 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.07% | -0.02% | -1.24% | |
| 47 | 62C | Piper Sandler Cos | 股票-其他 | 0.06% | — | — | |
| 48 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.06% | -0.23% | EXIT | |
| 49 | ✓ | Alpha Modus Hldgs Inc | 股票-其他 | 0.06% | -0.04% | EXIT | |
| 50 | BNAIW | Brand Engagement Netwo -cw27 | 股票-其他 | 0.03% | -0.08% | +63.56% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | CMPX | Compass Therapeutics Inc | +2.9% | +33.76% | 加仓 |
| 2 | CGEM | Cullinan Therapeutics Inc | +2.9% | -6.37% | 减仓 |
| 3 | ✓ | Engene Holdings Inc | +2.4% | +2.53% | 加仓 |
| 4 | LRMR | Larimar Therapeutics Inc | +2.2% | +16.58% | 加仓 |
| 5 | 4XC1 | Kalvista Pharmaceuticals Inc | +1.3% | +188.00% | 加仓 |
| 6 | CNTX | Context Therapeutics Inc | +1.1% | +0.34% | 加仓 |
| 7 | RPTX | Repare Therapeutics Inc | +0.9% | — | 不变 |
| 8 | EYPT | Eyepoint Inc | +0.6% | +6.80% | 加仓 |
| 9 | HLLY | Holley Inc | +0.6% | -14.72% | 减仓 |
| 10 | IMA | Imagenebio Inc | +0.4% | +52.29% | 加仓 |
| 11 | CVEO | Civeo CORP | +0.4% | +16.74% | 加仓 |
| 12 | NIOBW | Niocorp Developments LTD -28 | +0.2% | +60.34% | 加仓 |
| 13 | IMRX | Immuneering CORP - Class A | +0.2% | +20.91% | 加仓 |
| 14 | ELDN | Eledon Pharmaceuticals Inc | +0.1% | +96.95% | 加仓 |
| 15 | MRKR | Marker Therapeutics Inc | +0.1% | — | 不变 |
| 16 | ✓ | Alpha Modus Hldgs Inc | -0.1% | — | 不变 |
| 17 | ✓ | Rezolve Ai LTD | -0.1% | -1.24% | 减仓 |
| 18 | CMPS | Compass Pathways PLC | -0.1% | -22.32% | 减仓 |
| 19 | TTAN | Servicetitan Inc-a | -0.1% | -54.26% | 减仓 |
| 20 | SHFS | Shf Holdings Inc | -0.2% | — | 不变 |
| 21 | FLD | Fold Holdings Inc | -0.2% | — | 不变 |
| 22 | 260 | Centessa Pharmaceuticals-adr | -0.2% | -17.70% | 减仓 |
| 23 | DELL | Dell Technologies -c | -0.2% | +2.89% | 加仓 |
| 24 | PLRX | Pliant Therapeutics Inc | -0.2% | — | 不变 |
| 25 | MLYS | Mineralys Therapeutics Inc | -0.5% | -34.67% | 减仓 |
| 26 | PVLA | Palvella Therapeutics Inc | -0.6% | -57.74% | 减仓 |
| 27 | SGMT | Sagimet Biosciences Inc-a | -0.6% | -6.36% | 减仓 |
| 28 | CNDT | Conduent Inc | -1% | +8.20% | 加仓 |
| 29 | AQST | Aquestive Therapeutics Inc | -1.1% | -58.00% | 减仓 |
| 30 | RARE | Ultragenyx Pharmaceutical In | -2.4% | -49.66% | 减仓 |
| 31 | ROIV | Roivant Sciences Ltd. | -2.9% | -73.36% | 减仓 |
| 32 | NCDL | Nuveen Churchill Direct Lend | -4.4% | -30.66% | 减仓 |
| 33 | EVCM | Evercommerce Inc | — | EXIT | 清仓 |
| 34 | PCOR | Procore Technologies Inc | — | NEW | 新建仓 |
| 35 | IRON | Disc Medicine Inc | — | EXIT | 清仓 |
| 36 | MPLT | Maplight Therapeutics Inc | — | NEW | 新建仓 |
| 37 | IMMX | Immix Biopharma Inc | — | NEW | 新建仓 |
| 38 | KRRO | Korro Bio Inc | — | EXIT | 清仓 |
| 39 | ORIC | Oric Pharmaceuticals Inc | — | NEW | 新建仓 |
| 40 | PAYO | Payoneer Global Inc | — | NEW | 新建仓 |
| 41 | MREO | Mereo Biopharma Group Pl-adr | — | EXIT | 清仓 |
| 42 | LENZ | Lenz Therapeutics Inc | — | NEW | 新建仓 |
| 43 | ACLXGBX | Arcellx Inc | — | EXIT | 清仓 |
| 44 | JANX | Janux Therapeutics Inc | — | NEW | 新建仓 |
| 45 | CHYM | Chime Financial Inc-cl A | — | NEW | 新建仓 |
| 46 | TNGX | Tango Therapeutics Inc | — | EXIT | 清仓 |
| 47 | GTLB | Gitlab Inc-cl A | — | EXIT | 清仓 |
| 48 | ✓ | Alpha Tau Medical LTD | — | NEW | 新建仓 |
| 49 | ✓ | — | NEW | 新建仓 | |
| 50 | OMDA | Omada Health Inc | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Blue Owl Capital Holdings LP 在 Q4 2025 季度的美股持仓总市值约为 US$6.6亿，共申报了 80 个公开持股仓位。
在 Q4 2025 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为：ENGENE HOLDINGS INC (9.4%)、NCDL (8.8%)、OBDC (8.1%)。其中最大持股仓位 ENGENE HOLDINGS INC 占据整体投资组合约 9.4% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
PCOR
市值: US$685.7万
本季最大获利了结 / 清仓标的
EVCM
前期市值: US$1827.5万
在 Q4 2025 季度中，Blue Owl Capital Holdings LP 共进行了 44 项持仓异动，包含新建仓 11 个仓位、加仓 13 个仓位、减仓 13 个仓位以及清仓 7 个仓位。 其中最大新建仓标的为 PCOR。 本季清仓仓位包含 EVCM。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。